Quality-Adjusted Life Years Accrued with Cabozantinib in Patients with Advanced Hepatocellular Carcinoma (AHCC) in the CELESTiAL Trial

被引：0

作者：

Venerito, Marino ^{[1
]}

Abou-Alfa, G. K. ^{[2
]}

Mollon, P. ^{[3
]}

Meyer, T. ^{[4
]}

Cheng, A. -L ^{[5
]}

El-Khoueiry, A. B. ^{[6
]}

Kelley, R. K. ^{[7
]}

Baron, A. D. ^{[8
]}

Benzaghou, F. ^{[9
]}

Valcheva, V. ^{[3
]}

Hazra, S. ^{[10
]}

Mangeshkar, M. ^{[10
]}

Freemantle, N. ^{[4
]}

机构：

[1] Univ Klinikum Magdeburg, Magdeburg, Germany

[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[3] Ipsen Pharma SAS, Boulogne, France

[4] UCL, London, England

[5] Staatliche Univ Taiwan, Taipei, Taiwan

[6] Norris Comprehens Canc Ctr, Los Angeles, CA USA

[7] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[8] Calif Pacific Med Ctr, San Francisco, CA USA

[9] Ipsen Innovat, Les Ulis, France

[10] Exelixis Inc, San Francisco, CA USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

174

引用

页码：61 / 61

页数：1

共 50 条

[31] The quality-adjusted life-years in the oncological patients’ health-related quality of life
Karolina Kucnerowicz
Agata Pietrzak
Witold Cholewiński
Piotr Martenka
Andrzej Marszałek
Ewa Burchardt
Erwin Strzesak
Scientific Reports, 12
[32] Quality of life and quality-adjusted life years of chronic schistosomiasis mansoni patients in Brazil in 2015
Nascimento, Gilmore Lima
Coutinho Domingues, Ana Lucia
de Alencar Ximenes, Ricardo Arraes
Itria, Alexander
Cruz, Luciane Nascimento
Fernandes de Oliveira, Maria Regina
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2018, 112 (05) : 238 - 244
[33] Life under the CABOSUN: Cabozantinib improves quality-adjusted survival in comparison with sunitinib
Aragon-Ching, Jeanny B.
Madan, Ravi A.
CANCER, 2020, 126 (24) : 5210 - 5212
[34] Utilitarianism and the measurement and aggregation of quality-adjusted life years
Dolan, P
HEALTH CARE ANALYSIS, 2001, 9 (01) : 65 - 76
[35] THE IMPACT OF LUNG TRANSPLANTATION ON QUALITY-ADJUSTED LIFE YEARS
Huang, D.
Shrestha, P.
Soong, A.
Leard, L.
Hays, S.
Golden, J.
Kukreja, J.
Blanc, P.
Singer, J.
JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (01) : 190 - 190
[36] The importance of perspective in the measurement of quality-adjusted life years
Richardson, J
Nord, E
MEDICAL DECISION MAKING, 1997, 17 (01) : 33 - 41
[37] Quality-adjusted Life Years or Composite Outcomes? Reply
Aberegg, Scott
Scales, Damon C.
Ferguson, Niall D.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (05) : 622 - 623
[38] Re: Quality-Adjusted Survival with First-Line Cabozantinib or Sunitinib for Advanced Renal Cell Carcinoma in the CABOSUN Randomized Clinical Trial (Alliance)
Laguna, Pilar M.
JOURNAL OF UROLOGY, 2021, 205 (06): : 1819 - 1820
[39] The visibility and divisibility of quality-adjusted life-years
Mullins, CD
CLINICAL THERAPEUTICS, 2005, 27 (08) : 1276 - 1277
[40] Vertebral fractures and quality-adjusted life years (QALYs).
Tosteson, ANA
Gabriel, SE
Moncur, MM
Grove, MR
Olson, D
Melton, LJ
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S261 - S261

← 1 2 3 4 5 →